Difference between revisions of "Team:CKWA-China"
Dragon210331 (Talk | contribs) |
Dragon210331 (Talk | contribs) |
||
| Line 221: | Line 221: | ||
<div class="inner-box"> | <div class="inner-box"> | ||
<div class="image-box"> | <div class="image-box"> | ||
| − | <video class="gl_video" id="gl_video_2" src=" | + | <video class="gl_video" id="gl_video_2" src="https://static.igem.org/mediawiki/2021/b/bb/T--CKWA-China--sp1.mp4" |
controls="“ture”"></video> | controls="“ture”"></video> | ||
</div> | </div> | ||
Revision as of 00:36, 20 October 2021
-
We Proudly Service
These Metro Markets
Flooring is a family-owned and operated business. we have been installing floorssince 1992 and have installed flooring and Tilling -
We Proudly Service
These Metro Markets
Flooring is a family-owned and operated business. we have been installing floorssince 1992 and have installed flooring and Tilling -
We Proudly Service
These Metro Markets
Flooring is a family-owned and operated business. we have been installing floorssince 1992 and have installed flooring and Tilling -
We Proudly Service
These Metro Markets
Flooring is a family-owned and operated business. we have been installing floorssince 1992 and have installed flooring and Tilling
LonEase
Recurrence of cancer after surgical treatment is a major problem facing mankind nowadays, and cancer recurrence is a great threat for cancer patients. For example, bladder cancer recurs in up to 24%-84% of patients 5 years after surgical resection, in which overexpression of C-MYC protein is associated with approximately 44%-69% of these cases. We have investigated that Lon protein from uropathogenic Escherichia coli (UPEC) can be effective enough to degrade C-MYC protein and thus inhibit the proliferation of cancer cells. We plan to produce highly active Lon protease from E. coli this year and use it to design a drug to improve the surgical prognosis of bladder cancer population with C-myc gene overexpression.